S&P 500   3,002.36 (+0.21%)
DOW   26,862.85 (+0.28%)
QQQ   192.14 (+0.15%)
AAPL   242.74 (+1.16%)
FB   185.07 (+1.50%)
MSFT   136.24 (-0.10%)
GOOGL   1,255.37 (+1.14%)
AMZN   1,766.84 (+0.06%)
CGC   21.34 (+0.90%)
NVDA   195.52 (-0.05%)
MU   44.31 (-0.78%)
BABA   170.08 (+0.11%)
TSLA   255.28 (-0.12%)
AMD   31.56 (+0.16%)
T   37.94 (-0.60%)
ACB   3.65 (+1.96%)
NFLX   272.84 (+2.30%)
BAC   31.31 (+0.35%)
GILD   66.04 (+0.27%)
DIS   131.44 (-0.73%)
S&P 500   3,002.36 (+0.21%)
DOW   26,862.85 (+0.28%)
QQQ   192.14 (+0.15%)
AAPL   242.74 (+1.16%)
FB   185.07 (+1.50%)
MSFT   136.24 (-0.10%)
GOOGL   1,255.37 (+1.14%)
AMZN   1,766.84 (+0.06%)
CGC   21.34 (+0.90%)
NVDA   195.52 (-0.05%)
MU   44.31 (-0.78%)
BABA   170.08 (+0.11%)
TSLA   255.28 (-0.12%)
AMD   31.56 (+0.16%)
T   37.94 (-0.60%)
ACB   3.65 (+1.96%)
NFLX   272.84 (+2.30%)
BAC   31.31 (+0.35%)
GILD   66.04 (+0.27%)
DIS   131.44 (-0.73%)
Log in

Celgene News Headlines (NASDAQ:CELG)

$104.37
-0.33 (-0.32 %)
(As of 10/23/2019 11:43 AM ET)
Today's Range
$104.06
Now: $104.37
$104.80
50-Day Range
$96.37
MA: $99.38
$104.93
52-Week Range
$58.59
Now: $104.37
$107.41
Volume718,446 shs
Average Volume3.70 million shs
Market Capitalization$73.97 billion
P/E Ratio13.71
Dividend YieldN/A
Beta1.42

Headlines

Celgene (NASDAQ CELG) News Headlines

Source:
DateHeadline
Ovizio Imaging Systems Announces iLine F and BioConnect Supply Agreements With Celgene Corporation - PRNewswireOvizio Imaging Systems Announces iLine F and BioConnect Supply Agreements With Celgene Corporation - PRNewswire
www.prnewswire.com - October 22 at 9:13 PM
$4.44 Billion in Sales Expected for Celgene Co. (NASDAQ:CELG) This Quarter$4.44 Billion in Sales Expected for Celgene Co. (NASDAQ:CELG) This Quarter
www.americanbankingnews.com - October 22 at 2:18 AM
Celgene (NASDAQ:CELG) Rating Reiterated by MizuhoCelgene (NASDAQ:CELG) Rating Reiterated by Mizuho
www.americanbankingnews.com - October 20 at 9:40 PM
$2.73 EPS Expected for Celgene Co. (NASDAQ:CELG) This Quarter$2.73 EPS Expected for Celgene Co. (NASDAQ:CELG) This Quarter
www.americanbankingnews.com - October 20 at 9:21 PM
Better Buy: Geron vs. Celgene - Motley FoolBetter Buy: Geron vs. Celgene - Motley Fool
www.fool.com - October 19 at 12:49 PM
A Giant Fund Sold Disney, Celgene Stock, Bought Morgan Stanley and Oracle - BarronsA Giant Fund Sold Disney, Celgene Stock, Bought Morgan Stanley and Oracle - Barron's
www.barrons.com - October 19 at 7:45 AM
Celgene (CELG) Earnings Expected to Grow: Should You Buy? - Yahoo FinanceCelgene (CELG) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
finance.yahoo.com - October 17 at 12:59 PM
Celgene (CELG) Earnings Expected to Grow: Should You Buy?Celgene (CELG) Earnings Expected to Grow: Should You Buy?
finance.yahoo.com - October 17 at 12:59 PM
4 Biotech Stocks That Are Set to Rally, Analyst Says4 Biotech Stocks That Are Set to Rally, Analyst Says
finance.yahoo.com - October 17 at 12:59 PM
Lilly's Pancreatic Cancer Candidate Fails in Phase III StudyLilly's Pancreatic Cancer Candidate Fails in Phase III Study
finance.yahoo.com - October 17 at 12:59 PM
Celgene and the Multiple Sclerosis Association of America Take the MS MindShift Initiative and “Brain Bulb” Hot Air Balloon to the Sky at Owl-O-Ween Festival to Educate on Multiple Sclerosis and Brain Health - Business WireCelgene and the Multiple Sclerosis Association of America Take the MS MindShift Initiative and “Brain Bulb” Hot Air Balloon to the Sky at Owl-O-Ween Festival to Educate on Multiple Sclerosis and Brain Health - Business Wire
www.businesswire.com - October 16 at 1:27 PM
Editas Inks Deal for Gene Editing Neurological Disease DrugsEditas Inks Deal for Gene Editing Neurological Disease Drugs
finance.yahoo.com - October 16 at 1:27 PM
Pancreatic Cancer Therapeutics Market Analysis Reveals Explosive Growth by 2025 | Merck, Celgene, NovartisPancreatic Cancer Therapeutics Market Analysis Reveals Explosive Growth by 2025 | Merck, Celgene, Novartis
www.marketwatch.com - October 16 at 8:26 AM
Celgene and the Multiple Sclerosis Association of America Take the MS MindShift Initiative and “Brain Bulb” Hot Air Balloon to the Sky at Owl-O-Ween Festival to Educate on Multiple Sclerosis and Brain HealthCelgene and the Multiple Sclerosis Association of America Take the MS MindShift Initiative and “Brain Bulb” Hot Air Balloon to the Sky at Owl-O-Ween Festival to Educate on Multiple Sclerosis and Brain Health
www.businesswire.com - October 16 at 6:41 AM
Global 20s Proteasome Market - SWOT Analysis, Industry Trends and Research with Forecast 2029Global 20s Proteasome Market - SWOT Analysis, Industry Trends and Research with Forecast 2029
www.marketwatch.com - October 11 at 6:59 PM
A Biotech Set to Dominate the Next 20 Years - Motley FoolA Biotech Set to Dominate the Next 20 Years - Motley Fool
www.fool.com - October 1 at 8:15 PM
Geron's Imetelstat Gets Fast Track Status for MyelofibrosisGeron's Imetelstat Gets Fast Track Status for Myelofibrosis
finance.yahoo.com - October 1 at 3:15 PM
Celgene Co. (NASDAQ:CELG) Expected to Post Quarterly Sales of $4.46 BillionCelgene Co. (NASDAQ:CELG) Expected to Post Quarterly Sales of $4.46 Billion
www.americanbankingnews.com - September 30 at 6:37 AM
Oncology Pharmaceuticals Market Astonishing Growth | Hoffmann-La Roche, Novartis, Celgene, JanssenOncology Pharmaceuticals Market Astonishing Growth | Hoffmann-La Roche, Novartis, Celgene, Janssen
www.marketwatch.com - September 29 at 6:59 PM
Celgene Co. (NASDAQ:CELG) Receives Consensus Recommendation of "Hold" from BrokeragesCelgene Co. (NASDAQ:CELG) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - September 29 at 1:47 PM
Bristol-Myers Squibb Plus Celgene - Yahoo FinanceBristol-Myers Squibb Plus Celgene - Yahoo Finance
finance.yahoo.com - September 27 at 6:21 PM
Incyte (INCY) Stock Up 16% YTD on Strong Jakafi PerformanceIncyte (INCY) Stock Up 16% YTD on Strong Jakafi Performance
finance.yahoo.com - September 27 at 1:21 PM
Regenerative Medicine Market to Eyewitness Massive Growth by 2025Regenerative Medicine Market to Eyewitness Massive Growth by 2025
www.marketwatch.com - September 26 at 3:23 PM
A Big Biotech Bet Hiding in Plain Sight - The Wall Street JournalA Big Biotech Bet Hiding in Plain Sight - The Wall Street Journal
www.wsj.com - September 24 at 8:32 AM
Celgene (CELG) Gains As Market Dips: What You Should Know - NasdaqCelgene (CELG) Gains As Market Dips: What You Should Know - Nasdaq
www.nasdaq.com - September 24 at 3:31 AM
Blockbuster Drugs Market Analysis|Players are AbbVie, Celgene,Merck and RocheBlockbuster Drugs Market Analysis|Players are AbbVie, Celgene,Merck and Roche
www.marketwatch.com - September 23 at 10:30 PM
Celgene (CELG) Gains As Market Dips: What You Should KnowCelgene (CELG) Gains As Market Dips: What You Should Know
finance.yahoo.com - September 23 at 10:30 PM
Bladder Cancer Market 2019 | Size, Share, Trend, Global Demand, Industry Statistics and Current Scenario by Forecast to 2023Bladder Cancer Market 2019 | Size, Share, Trend, Global Demand, Industry Statistics and Current Scenario by Forecast to 2023
www.benzinga.com - September 20 at 2:52 PM
Celgene Corporation Names Second Round of Celgene Cancer Care Links™ Program Grant Recipients - Yahoo FinanceCelgene Corporation Names Second Round of Celgene Cancer Care Links™ Program Grant Recipients - Yahoo Finance
finance.yahoo.com - September 20 at 9:43 AM
Celgene Corporation Names Second Round of Celgene Cancer Care Links™ Program Grant RecipientsCelgene Corporation Names Second Round of Celgene Cancer Care Links™ Program Grant Recipients
finance.yahoo.com - September 20 at 9:43 AM
3 Big Biotech Stocks Worth Adding to Your Portfolio Now3 Big Biotech Stocks Worth Adding to Your Portfolio Now
finance.yahoo.com - September 20 at 9:43 AM
Top Stock Reports for Celgene, Sinopec & HSBCTop Stock Reports for Celgene, Sinopec & HSBC
finance.yahoo.com - September 16 at 7:47 PM
Amgen's Kyprolis Combo Improves PFS in Multiple Myeloma StudyAmgen's Kyprolis Combo Improves PFS in Multiple Myeloma Study
finance.yahoo.com - September 16 at 10:58 AM
Better Buy: Celgene vs. Gilead Sciences - Motley FoolBetter Buy: Celgene vs. Gilead Sciences - Motley Fool
www.fool.com - September 14 at 1:18 PM
Celgenes CC-486 successful in late-stage AML study - Seeking AlphaCelgene's CC-486 successful in late-stage AML study - Seeking Alpha
seekingalpha.com - September 13 at 1:58 PM
Celgenes (CELG) Leukemia Candidate Meets Endpoints in Study - Yahoo FinanceCelgene's (CELG) Leukemia Candidate Meets Endpoints in Study - Yahoo Finance
finance.yahoo.com - September 13 at 1:58 PM
Celgene (CELG) Outpaces Stock Market Gains: What You Should KnowCelgene (CELG) Outpaces Stock Market Gains: What You Should Know
finance.yahoo.com - September 12 at 9:53 AM
Global Revlimid Market 2019 – CelgeneGlobal Revlimid Market 2019 – Celgene
www.marketwatch.com - September 11 at 10:32 AM
50 Blockbuster Drugs Market is expected to reach Usd$ 292 Billion By 2025|AbbVie, Celgene, Gilead Science50 Blockbuster Drugs Market is expected to reach Usd$ 292 Billion By 2025|AbbVie, Celgene, Gilead Science
www.marketwatch.com - September 11 at 10:32 AM
Data from Ozanimod Clinical Development Program in Relapsing Forms of Multiple Sclerosis to Be Presented at the 35th Congress of the European Committee for Treatment and Research in Multiple SclerosisData from Ozanimod Clinical Development Program in Relapsing Forms of Multiple Sclerosis to Be Presented at the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
finance.yahoo.com - September 9 at 1:23 PM
Why Amgen's Spending Billions to Buy This 1 Drug; Plus Heart Disease Has a New EnemyWhy Amgen's Spending Billions to Buy This 1 Drug; Plus Heart Disease Has a New Enemy
finance.yahoo.com - September 7 at 10:53 AM
Why Im Big On The Celgene/Bristol-Myers Deal - Seeking AlphaWhy I'm Big On The Celgene/Bristol-Myers Deal - Seeking Alpha
seekingalpha.com - September 6 at 6:24 AM
Celgene (CELG) Gains But Lags Market: What You Should Know - Yahoo FinanceCelgene (CELG) Gains But Lags Market: What You Should Know - Yahoo Finance
finance.yahoo.com - September 6 at 6:24 AM
China biotech group shares slide over accusation of sales inflationChina biotech group shares slide over accusation of sales inflation
finance.yahoo.com - September 6 at 6:24 AM
Roche Extends Offer to Acquire Spark Therapeutics Yet AgainRoche Extends Offer to Acquire Spark Therapeutics Yet Again
finance.yahoo.com - September 4 at 3:58 PM
Celgene (CELG) Stock Sinks As Market Gains: What You Should KnowCelgene (CELG) Stock Sinks As Market Gains: What You Should Know
finance.yahoo.com - August 30 at 9:31 PM
Why Is Celgene (CELG) Up 6.1% Since Last Earnings Report? - NasdaqWhy Is Celgene (CELG) Up 6.1% Since Last Earnings Report? - Nasdaq
www.nasdaq.com - August 30 at 4:31 PM
Why Is Celgene (CELG) Up 6.1% Since Last Earnings Report? - Yahoo FinanceWhy Is Celgene (CELG) Up 6.1% Since Last Earnings Report? - Yahoo Finance
finance.yahoo.com - August 29 at 3:58 PM
Why Is Celgene (CELG) Up 6.1% Since Last Earnings Report?Why Is Celgene (CELG) Up 6.1% Since Last Earnings Report?
finance.yahoo.com - August 29 at 3:58 PM
Geron (GERN) Stock Rises 40% in 2019 So Far: Here's WhyGeron (GERN) Stock Rises 40% in 2019 So Far: Here's Why
finance.yahoo.com - August 29 at 3:58 PM
This page was last updated on 10/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel